Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2020 Mar 3;20:81. doi: 10.1186/s12886-020-01343-x

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2020

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 1 — Efficacy of mydriasis in diabetic and non-diabetic patients (mITT set) who received ICMA for intracameral injection at the beginning of cataract surgery (Mydrane) or a standard topical regimen (Topical) for cataract surgery. a Successful capsulorhexis without any additional mydriatic treatment (Primary efficacy variable). b Successful capsulorhexis without any additional mydriatic treatment and a pupil size of at least 6 mm (Supplementary efficacy variable). ICMA = intracameral combination of two mydriatics and one anaesthetic; p < 0.05 is statistically significant